Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F7 | P08709 | 5/20 | 0.51 |
| ▸ | F3 | P13726 | 5/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.51 |
| ▸ | CYP19A1 | P11511 | 4/20 | 0.51 |
| ▸ | MAPT | P10636 | 4/20 | 0.51 |
| ▸ | PPARG | P37231 | 4/20 | 0.51 |
| ▸ | PPARD | Q03181 | 4/20 | 0.51 |
| ▸ | PPARA | Q07869 | 4/20 | 0.51 |
| ▸ | BLM | P54132 | 4/20 | 0.51 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.51 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.51 |
| ▸ | OXER1 | Q8TDS5 | 2/20 | 0.51 |
| ▸ | LMNA | P02545 | 2/20 | 0.51 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.51 |
| ▸ | RECQL | P46063 | 2/20 | 0.51 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.51 |
| ▸ | MEN1 | O00255 | 1/20 | 0.51 |
| ▸ | FFAR1 | O14842 | 1/20 | 0.51 |
| ▸ | NR1I2 | O75469 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4308676 | 1.00 | F7 (0.51) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL6436579 | 1.00 | F7 (0.51) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL15463523 | 1.00 | F7 (0.51) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL6436582 | 1.00 | F7 (0.51) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL4308674 | 1.00 | F7 (0.51) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL3740203 | 0.98 | ALDH1A1 (0.49) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL2984576 | 0.95 | ALDH1A1 (0.60) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL22635677 | 0.95 | ALDH1A1 (0.60) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL3213389 | 0.95 | ALDH1A1 (0.60) | F7F3ALDH1A1CYP19A1MAPT | |
| SCHEMBL2984578 | 0.95 | ALDH1A1 (0.60) | F7F3ALDH1A1CYP19A1MAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10011554-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | Givaudan, S.A. (CH) | 2018-07-03 | — | — | US | claimed |
| US-20170327452-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN S.A. (CH) | 2017-11-16 | — | — | US | claimed |
| US-9745245-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | GIVAUDAN S.A. (CH) | 2017-08-29 | — | — | US | claimed |
| EP-2370391-B1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2014-02-12 | — | — | EP | claimed |
| US-20110263725-A1 | Alpha-branched Alkenoic Acids and the Use of Alpha-branched Alkanoic and Alkenoic Acids as a Fragrance | GIVAUDAN SA (CH) | 2011-10-27 | — | — | US | claimed |
| EP-2370391-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | Givaudan SA (CH) | 2011-10-05 | — | — | EP | claimed |
| WO-2010063133-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2010-06-10 | — | — | WO | claimed |
| US-10011554-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | Givaudan, S.A. (CH) | 2018-07-03 | — | — | US | disclosed |
| US-20170327452-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN S.A. (CH) | 2017-11-16 | — | — | US | disclosed |
| US-9745245-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | GIVAUDAN S.A. (CH) | 2017-08-29 | — | — | US | disclosed |
| EP-2370391-B1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2014-02-12 | — | — | EP | disclosed |
| US-20110263725-A1 | Alpha-branched Alkenoic Acids and the Use of Alpha-branched Alkanoic and Alkenoic Acids as a Fragrance | GIVAUDAN SA (CH) | 2011-10-27 | — | — | US | disclosed |
| EP-2370391-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | Givaudan SA (CH) | 2011-10-05 | — | — | EP | disclosed |
| WO-2010063133-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | GIVAUDAN SA (CH) | 2010-06-10 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10011554-B2 | Alpha-branched alkenoic acids and the use of alpha-branched alkanoic and alkenoic acids as a fragrance | FASN, ELOVL1, ACOX1 | F7 173/4885F3 879/4885ALDH1A1 50/4885 |
| US-20110263725-A1 | Alpha-branched Alkenoic Acids and the Use of Alpha-branched Alkanoic and Alkenoic Acids as a Fragrance | FASN, ELOVL1, ACOX1 | F7 173/4885F3 879/4885ALDH1A1 50/4885 |
| US-20170327452-A1 | ALPHA-BRANCHED ALKENOIC ACIDS AND THE USE OF ALPHA-BRANCHED ALKANOIC AND ALKENOIC ACIDS AS A FRAGRANCE | FASN, ELOVL1, ACOX1 | F7 173/4885F3 879/4885ALDH1A1 50/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.